Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Introducción del caso

This program is divided into several short segments that you can access using the Video Chapters menu.
person default
Ariel Campos, MD
Luis E. Soto-Ramirez, MD
Released: July 29, 2022
PreviousNext

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Information on this Educational Activity

Faculty

Ariel Campos, MD

Adjunct Professor
Infectious Diseases
Universidad de Guadalajara
Guadalajara, Mexico
Infectious Diseases Physician and HIV-AIDS Specialist
HIV-AIDS Unit
Jalisco, Mexico

Ariel Eduardo Campos Loza, MD, no tiene relaciones financieras que revelar.
Luis E. Soto-Ramirez, MD

Head, Molecular Virology Lab
Department of Infectious Diseases
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
Head, Infectious Diseases and Epidemiology
Hospital Médica Sur
Mexico City, Mexico

Luis E. Soto-Ramírez, MD, ha revelado que ha recibido honorarios por consultoría de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen y honorarios por servicios que no son CME/CE de GlaxoSmithKline/ViiV Healthcare, Merck Sharp & Dohme y Janssen.

Staff

Courtney Smith, PharmD, MS
Courtney Smith, PharmD, MS, has no relevant conflicts of interest to report.
Zachary Schwartz, MSc

Scientific Director

Zachary Schwartz, MSc, ELS, has no relevant conflicts of interest to report.
Petra Cravens, PhD

Editorial Contributor

Petra Cravens, PhD, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Related Content

An expert panel of healthcare professionals and patient advocates discuss barriers faced by aging patients with HIV, from Clinical Care Options (CCO)

Jonathan Appelbaum, MD, FACP, AAHIVS
Program Director
Lydia Mungherera, MBChB Cristina Mussini, MD Dorothy Onyango Melanie Reese Marc Thompson
Released: September 23, 2022

Expert selections of cutting-edge HIV data, including the latest on long-acting therapies and pre-exposure prophylaxis

Joseph J. Eron, Jr., MD
Program Director
Jeffrey Kwong, DNP, MPH, FAANP, FAAN
Program Director
Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Darcy Wooten, MD
Released: September 23, 2022

Expert analysis of barriers and solutions to PrEP uptake in key populations

Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP
Program Director
Released: September 23, 2022

Expert selections of important HIV data from AIDS 2022, including current and investigational strategies for prevention, ART, comorbidities, and cure

Joseph J. Eron, Jr., MD Jeffrey Kwong, DNP, MPH, FAANP, FAAN Milena Murray, PharmD, MSc, BCIDP, AAHIVP, FCCP David A. Wohl, MD Released: September 23, 2022

Video Chapters


Beca educativa proporcionada por:
ViiV Healthcare

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings